|
1.
|
|
12 p, 780.3 KB |
Observational cohort study of rilpivirine (RPV) utilization in Europe
/
Cozzi-Lepri, Alessandro (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ;
Peters, Lars (CHIP. Rigshospitalet. University of Copenhagen) ;
Pelchen-Matthews, Annegret (Centre for Clinical Research. Epidemiology. Modelling and Evaluation (CREME). Institute for Global Health. University College London) ;
Neesgaard, Bastian (CHIP. Rigshospitalet. University of Copenhagen (Belgium)) ;
De Wit, Stéphane (Université Libre de Bruxelles, Department of Infectious Diseases) ;
Johansen, Isik Somuncu (Odense University Hospital (Dinamarca)) ;
Edwards, Simon (Mortimer Market Centre, Department of HIV (London)) ;
Stephan, Christoph (Infectious Diseases Unit. Goethe-University Hospital) ;
Adamis, Georgios (General Hospital of Athens G. Gennimatas (Greece)) ;
Staub, Therese (Centre Hospitalier de Luxembourg, Service des Maladies Infectieuses (Luxembourg)) ;
Zagalo, Alexandra (Santa Maria University Hospital, Department of Infectious Diseases (Lisbon, Portugal)) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Elbirt, Daniel (Allergy. Immunology and HIV Unit | Kaplan. Medical Center) ;
Kusejko, Katharina (University Hospital Zürich (Switzerland)) ;
Brännström, Johanna (Department of Infectious Diseases. Venhälsan Södersjukhuset) ;
Paduta, Dzmitry (Gomel Regional Centre for Hygiene) ;
Trofimova, Tatyana (Novgorod Centre for AIDS Prevention and Control) ;
Szlavik, Janos (South-Pest Hospital Centre-National Institute for Infectiology and Haematology) ;
Zilmer, Kai (West-Tallinn Central Hospital, Infectious Diseases Clinic (Talinn, Estonia)) ;
Losso, Marcello (Hospital J.M. Ramos Mejia (Buenos Aires)) ;
Van Eygen, Veerle (Janssen Research & Development) ;
Pai, Helen (Janssen Research & Development) ;
Lundgren, Jens (CHIP. Rigshospitalet. University of Copenhagen) ;
Mocroft, Amanda (Rigshospitalet. University of Copenhagen (Denmark)) ;
Harxhi, Arjan (Medical University of Tirana (Albania)) ;
Losso, Marcelo Horacio (Hospital General de Agudos JM Ramos Mejía (Buenos Aires)) ;
Kundro, Mariana (Hospital General de Agudos JM Ramos Mejía (Buenos Aires)) ;
Schmied, Brigitte (Institute of Science and Technology Austria (ISTA)) ;
Karpov, Igor Alexandrovich (Belarusian State Medical University (Minsk)) ;
Vassilenko, Anna (Belarusian State Medical University (Minsk)) ;
Paduto, Dmitriy (Regional AIDS Centre (Svetlogorsk, Bèlgica)) ;
Mitsura, Victor (Gomel State Medical University) ;
Clumeck, Nathan (University Hospital Brussels) ;
De Wit, Stéphane A. (Université Libre de Bruxelles) ;
Delforge, Marc D. (Université Libre de Bruxelles) ;
Hadziosmanovic, Vesnadarjan (Clinical Center University of Sarajevo) ;
Begovac, Josip (University of Zagreb) ;
Machala, Ladislav (Charles University in Prague) ;
Jilich, David (Charles University in Prague) ;
Gerstoft, Jan (IT University of Copenhagen) ;
Torp-Pedersen, Christian (Aalborg Universitet) ;
Sedlacek, Dalibor (Fakultní nemocnice Plzeň) ;
Kronborg, Gitte (University of Copenhagen) ;
Benfield, Thomas (Copenhagen University Hospital Hvidovre) ;
Johansen, IS (Odense University Hospital (Dinamarca)) ;
Ostergaard, Leif (Aarhus University) ;
Wiese, Lothar (Roskilde University) ;
Friis-Moller, Nina (Zealand University Hospital) ;
Nielsen, Lars Norregård (Hillerod Hospital (Hillerod, Dinamarca)) ;
Zilmer, Kai (Kaunas University of Technology) ;
Smidt, Jelena (Kohtla - Jarve Jarve Gümnaasium) ;
Aho, Inka (Helsinki University Central Hospital) ;
Viard, Jean-Paul (Université Paris Cité) ;
Girard, Pierre-Marie (University of Paris-Est) ;
Pradier, Christian (Centre Hospitalier Universitaire de Nice) ;
Fontas, Eric (Centre Hospitalier Universitaire de Nice) ;
Duvivier, Claudine (Hôpital Universitaire Necker) ;
Rockstroh, Jurgen (Universitätsklinikum Bonn) ;
Degen, Olaf (University Medical Center Hamburg) ;
Hoffmann, C. (IPM Study Center) ;
Stellbrink, H.J. (IPM Study Center) ;
Stefan, C. (JW Goethe University Hospital (Frankfurt)) ;
Bogner, Johannes (University Hospital München) ;
Fätkenheuer, Gerd (University of Cologne) ;
Chkhartishvili, N. (Infectious Diseases, AIDS and Clinical Immunology Research Center) ;
Sambatakou, Helen (Hippokration General Hospital (Athens)) ;
Paissios, N. (Athens General Hospital "G Gennimatas") ;
Uzdaviniene, V. (Vilnius University Hospital Santariskiu Clinics) ;
Staub, T. (Centre Hospitalier de Luxembourg) ;
Dragas, S. ;
Reiss, P. (University of Amsterdam) ;
Trajanovska, J. (University Clinic for Infectious Diseases & Febrile Conditions (Skopje)) ;
Reikvam, Dag Henrik (Oslo University Hospital (Oslo, Noruega)) ;
Maeland, A. (Oslo University Hospital (Oslo, Noruega)) ;
Bruun, Johan (University Hospital of North Norway) ;
Knysz, B. (WWF Poland) ;
Szetela, Bartosz (Nicolaus Copernicus University) ;
Inglot, Malgorzata (Wroclaw Medical University) ;
Bakowska, E. (Hospital For Infectious Diseases (Warsaw)) ;
Flisiak, Robert (Medical University of Bialystok) ;
Grzeszczuk, Anna (Medical University of Bialystok) ;
Parczewski, Miłosz (Pomeranian Medical University in Szczecin) ;
Maciejewska, Katarzyna (Pomeranian Medical University in Szczecin) ;
Aksak-Was, Bogusz (Pomeranian Medical University in Szczecin) ;
Beniowski, Marek (Medical University of Silesia in Katowice) ;
Mularska, Elżbieta ;
Jablonowska, Elżbieta (University of Lodz) ;
Kamerys, J. (Poznan University of Medical Sciences) ;
Wojcik, K. (University of Lodz) ;
Mozer-Lisewska, Iwona (Uniwersytet Medyczny im.Karola Marcinkowskiego w Poznaniu) ;
Rozplochowski, Błażej (Poznan University of Medical Sciences) ;
Zagalo, A. (Hospital Santa Maria (Lisboa, Portugal)) ;
Radoi, Roxana (Clinical Hospital Of Infectious Diseases "Dr. Victor Babes") ;
Oprea, Cris (Joint Institute for Nuclear Research) ;
Yakovlev, A. (Saint Petersburg State University) ;
Trofimora, T. (Novgorod Centre for AIDS (Novgorod)) ;
Khromova, I. (Tomsk Regional Center of AIDS and infectious diseases prophylaxis and control" (RCAIDPC)) ;
Kuzovatova, Elena (Blokhina Scientific Research Institute of Epidemiology and Microbiology of Nizhny Novgorod) ;
Borodulina, Elena (Samara State Medical University) ;
Vdoushkina, Elena (Samara State Medical University) ;
Ranin, Jovan (Klinički centar Srbije) ;
Tomazic, J. (Ljubljana University Medical Centre) ;
Miro, Josep M. (Instituto de Salud Carlos III) ;
Laguno, Montse (Hospital Clínic i Provincial de Barcelona) ;
Martinez, E. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Garcia, F. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Blanco, J.L. (Hospital Clínic i Provincial de Barcelona) ;
Martinez-Rebollar, María (Hospital Clínic i Provincial de Barcelona) ;
Mallolas, J. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Callau, Pilar (Universitat de Barcelona) ;
Rojas, J. (Hospital Clínic i Provincial de Barcelona) ;
Moreno, Santiago (Pontifical Catholic University of Argentina) ;
del Campo, Santos (Hospital Universitario Ramón y Cajal (Madrid)) ;
Jou, A. (IrsiCaixa Institute for AIDS Research) ;
Paredes, Roger (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Puig, Jordi (Universitat Autònoma de Barcelona) ;
Llibre, Josep M.. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santos, J.R. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Domingo, Pere (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Gutierrez, M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Mateo, G.M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Sambeat, A. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Laporte, J.M. (Hospital Universitario de Alava) ;
Svedhem, V. (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Thalme, Anders (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Sonnerborg, A. (Karolinska University Hospital) ;
Flamholc, L. (Skåne University Hospital (Suècia)) ;
Kusejko, Katharina (University of Zurich) ;
Weber, R. (Universitäts-Herzzentrum Freiburg - Bad Krozingen) ;
Calmy, Alexandra (University of Geneva) ;
Furrer, Hansjakob (Inselspital, Universitätsspital Bern) ;
Battegay, Manuel (University of Basel) ;
Schmid, P. (Cantonal Hospital of Schwyz) ;
Kuznetsova, A. (Kyiv National Economic University) ;
Mikhalik, Julia (Crimean Republican AIDS centre) ;
Sluzhynska, M. (International HIV/AIDS Alliance in Ukraine) ;
Milinkovic, Ana (Imperial College London) ;
Johnson, A.M. (Mortimer Market Centre) ;
Simons, Edwards (Mortimer Market Centre) ;
Edwards, S. (Brookhaven National Laboratory) ;
Phillips, A.M. (Royal Free and University College Medical School) ;
Johnson, M.A. (Royal Free and University College Medical School) ;
Mocroft, A. (Royal Free and University College Medical School) ;
Orkin, Chloe (Queen Mary, University of London) ;
Winston, Alan (Imperial College London) ;
Clarke, A. (University of Sussex) ;
Leen, Clifford (The University of Edinburgh)
Introduction: Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce. Methods: Participants of EuroSIDA were included if they had started a RPV- or an EFV-containing regimen over November 2011-December 2017. [...]
2022 -  10.1186/s12981-022-00457-0
AIDS Research and Therapy, Vol. 19 Núm. 1 (december 2022) , p. 38
|
|
|
3.
|
|
7 p, 214.7 KB |
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression
/
Llibre, Josep M. (Institut Germans Trias i Pujol. Fundació Lluita Contra les Infeccions) ;
Cozzi-Lepri, Alessandro (University College London, UK) ;
Pedersen, Court (Odense University Hospital (Dinamarca)) ;
Ristola, Matti (Helsinki University Hospital (Finlàndia)) ;
Losso, Marcelo (Hospital General de Agudos JM Ramos Mejía, Buenos Aires, Argentina) ;
Mocroft, Amanda (University College London, UK) ;
Mitsura, Viktar (Gomel State Medical University, Belarus) ;
Falconer, Karolin (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Maltez, Fernando (Curry Cabral Hospital, Lisboa, Portugal) ;
Beniowski, Marek (Specialistic Hospital, Chorzów, Poland) ;
Vullo, Vincenzo (Policlinico Umberto 1, Rome, Italy) ;
Hassoun, Gamal (Rambam-Health Care Campus, Haifa, Israel) ;
Kuzovatova, Elena (Nizhny Novgorod Scientific and Research Institute of Epidemiology and Microbiology named after Academician I.N. Blokhina, Russia) ;
Szlavik, János (St László Hospital (Hongria)) ;
Kuznetsova, Anastasiia (Kharkov State Medical University, Ukraine) ;
Stellbrink, Hans-Jürgen (ICH Study Center, Hamburg, Germany) ;
Duvivier, Claudine (APHP-Hôpital Necker-Enfants Malades, Paris, France) ;
Edwards, Simon (Mortimer Market Centre, UK) ;
Laut, Kamilla (Centre for Health & University of Copenhagen, Denmark) ;
Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa)
Effectiveness data of an unboosted atazanavir (ATV) with abacavir/lamivudine (ABC/3TC) switch strategy in clinical routine are scant. We evaluated treatment outcomes of ATV + ABC/3TC in pretreated subjects in the EuroSIDA cohort when started with undetectable plasma HIV-1 viral load (pVL), performing a time to loss of virological response (TLOVR <50 copies/mL) and a snapshot analysis at 48, 96, and 144 weeks. [...]
2016 - 10.1097/MD.0000000000005020
Medicine, Vol. 95, Num. 40 (october 2016)
|
|
|
5.
|
|
11 p, 354.4 KB |
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART : a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing
/
Cozzi-Lepri, Alessandro (University College London) ;
Noguera-Julian, Marc (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Di Giallonardo, Francesca (University Hospital Zurich (Suïssa)) ;
Schuurman, Rob (Department of Virology. University Medical Centre, Utrecht) ;
Däumer, Martin (Institut für Immunologie und Genetik, Kaiserslautern, Germany) ;
Aitken, Sue (Department of Virology. University Medical Centre, Utrecht) ;
Ceccherini-Silberstein, Francesca (Department of Experimental Medicine and Surgery, University of Rome Tor Vergata) ;
D'Arminio Monforte, Antonella (Clinic of Infectious Diseases, 'San Paolo' Hospital) ;
Geretti, Anna Maria (Institute of Infection & Global Health, University of Liverpool) ;
Booth, Clare L. (Department of Virology, Royal Free London NHS Foundation Trust) ;
Kaiser, Rolf (Institute of Virology, University of Cologne) ;
Michalik, Claudia (Competence Network for HIV/AIDS, Bochum, Germany) ;
Jansen, Klaus (Competence Network for HIV/AIDS, Bochum, Germany) ;
Masquelier, Bernard (Université Bordeaux 2) ;
Bellecave, Pantxika (Université Bordeaux 2) ;
Kouyos, Roger D. (University Hospital Zurich (Suïssa)) ;
Castro, Erika (Centre Hospitalier Universitaire Vaudois (Lausanne, Suïssa). Service of Community Psychiatry) ;
Furrer, Hansjakob (Bern University Hospital) ;
Schultze, Anna (University College London) ;
Günthard, Huldrych F. (University Hospital Zurich (Suïssa)) ;
Brun-Vezinet, Francoise (Department of Virology, Bichat University Hospital, Paris) ;
Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ;
Metzner, Karin J. (University Hospital Zurich (Suïssa)) ;
CHAIN Minority HIV-1 Variants Working Group
It is still debated if pre-existing minority drug-resistant HIV-1 variants (MVs) affect the virological outcomes of first-line NNRTI-containing ART. This Europe-wide case-control study included ART-naive subjects infected with drug-susceptible HIV-1 as revealed by population sequencing, who achieved virological suppression on first-line ART including one NNRTI. [...]
2014 - 10.1093/jac/dku426
Journal of antimicrobial chemotherapy, Vol. 70 (october 2014) , p. 930-940
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
